Home

Gilead Sciences, Inc. - Financial Overview

Ticker - GILD

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$112.46$139.89B23.615.113.5%8.7%7.3

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $24.7B $123.0M $0.10 N/A N/A N/A
1 2021-12-31 $27.3B $6.2B $4.96 10.6% 4961.0% 4860.0%
2 2022-12-31 $27.3B $4.6B $3.66 -0.1% -26.2% -26.2%
3 2023-12-31 $27.1B $5.7B $4.54 -0.6% 23.4% 24.0%
4 2024-12-31 $28.8B $480.0M $4.54 6.0% -91.5% 0.0%
5 TTM 2025-03-31 $22.1B $4.7B $4.76 -23.3% 868.8% 4.8%
6 Average -1.5% 1147.1% 972.5%




GILD - Forecast Data



GILD - Y/Y % Change

  Metric Value
0 Total Assets $56,434M
1 Cash $7,926M
2 Total Liabilities $37,356M
3 Total Debt $24,952M
4 Total Equity $19,162M
5 Debt to Equity Ratio 1.30
GILD Balance Sheet Chart


GILD - Expense Overview



GILD - Unmapped Expense Line Items

No unmapped expenses.



GILD - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$112.46 4.5% Nicks Growth: 2%
Nick's Expected Margin: 15%
FINVIZ Growth: 26%
Nicks: 8
Finviz: 69
Nick's: 1.163 4.9 23.6
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$4.76 EPS TTM $36.92 -67.2% $328.53 192.1%
$7.91 EPS 2025 $61.34 -45.5% $545.94 385.5%
$8.39 EPS 2026 $65.07 -42.1% $579.07 414.9%